Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
Crossref DOI link: https://doi.org/10.1007/s11060-014-1635-7
Published Online: 2014-10-31
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hunn, Martin K.
Bauer, Evelyn
Wood, Catherine E.
Gasser, Olivier
Dzhelali, Marina
Ancelet, Lindsay R.
Mester, Brigitta
Sharples, Katrina J.
Findlay, Michael P.
Hamilton, David A.
Hermans, Ian F.
Text and Data Mining valid from 2014-10-31